nach oben

Current Neurology and Neuroscience Reports

Erschienen in:

01.02.2013 | STROKE (HP ADAMS JR, SECTION EDITOR)

Diagnosis and Treatment of Arteriovenous Malformations

verfasst von: J. P. Mohr, J. Kejda-Scharler, J. Pile-Spellman

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Brain arteriovenous malformations (bAVMs) are among the least common of causes of brain hemorrhage, seizures, or headaches. Embedded in the brain, their widely varying size, arterial feeders draining venous pattern and nidus complexity make them among the most challenging of disorders for attempted eradication. The low prevalence has created a literature long dominated by anecdote, only recently and slowly being clarified by epidemiological, pathophysiological, and imaging data. A first-ever randomized clinical trial seeks to determine if invasive intervention to eradicate the lesion—and its attendant risks of complications—offers a better prognosis than awaiting a hemorrhage before undertaking such efforts.

Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain. 2001;124:1900–26.PubMedCrossRef

Brown Jr RD, Wiebers DO, Torner JC, O'Fallon WM. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology. 1996;46:949–52.PubMedCrossRef

Al-Shahi R, Bhattacharya JJ, Currie DG, et al. Scottish Intracranial Vascular Malformation Study (SIVMS): evaluation of methods, ICD-10 coding, and potential sources of bias in a prospective, population-based cohort. Stroke. 2003;34:1156–62.PubMedCrossRef

Mohr JP, Wolf PA, Grotta J, et al. Stroke: pathophysiology, diagnosis, and management, 3 ed, Elsevier Saunders. 2011.

Yue NC, Longstreth Jr WT, Elster AD, et al. Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology. 1997;202:41–6.PubMed

Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA. 1999;282:36–9.PubMedCrossRef

Berman MF, Sciacca RR, Pile-Spellman J, et al. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2000; 47:389–96; discussion 97.

Willinsky RA, Lasjaunias P, Terbrugge K, Burrows P. Multiple cerebral arteriovenous malformations (AVMs). Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology. 1990;32:207–10.PubMedCrossRef

Leblanc GG, Golanov E, Awad IA, Young WL. Biology of vascular malformations of the brain. Stroke. 2009;40:e694–702.PubMedCrossRef

10.

Marks MP, Lane B, Steinberg GK, Chang PJ. Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants. Radiology. 1990;176:807–13.PubMed

11.

• Stefani MA, Porter PJ, terBrugge KG, et al. Angioarchitectural factors present in brain arteriovenous malformations associated with hemorrhagic presentation. Stroke. 2002;33:920–4. Detailed description of the may variations in arterial feeders and venous drainage.

12.

•• Duong DH, Young WL, Vang MC, et al. Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke. 1998;29:1167–76. Evidence that feeding artery pressure accounts for the major risk of rupture.

13.

Josephson CB, Bhattacharya JJ, Counsell CE, et al. Seizure risk with AVM treatment or conservative management: prospective, population-based study. Neurology. 2012;79:500–7.PubMedCrossRef

14.

Garcin B, Houdart E, Porcher R, et al. Epileptic seizures at initial presentation in patients with brain arteriovenous malformation. Neurology. 2012;78:626–31.PubMedCrossRef

15.

Hofmeister C, Stapf C, Hartmann A, et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke. 2000;31:1307–10.PubMedCrossRef

16.

Osipov A, Koennecke HC, Hartmann A, et al. Seizures in cerebral arteriovenous malformations: type, clinical course, and medical management. Interventional Neuroradiology. 1997;3:37–41.PubMed

17.

Ennoksson P, Bynke H. Visual field defects in arteriovenous aneurysma of the brain. Acta Ophtalmol. 1958;36:586.CrossRef

18.

Troost BT, Newton TH. Occipital lobe arteriovenous malformations: clinical and radiologic features in 26 cases with comments on differentiation from migraine. Arch Ophthalmol. 1975;93:250–6.PubMedCrossRef

19.

Englot DJ, Young WL, Han SJ, et al. Seizure predictors and control after microsurgical resection of supratentorial arteriovenous malformations in 440 patients. Neurosurgery. 2012;71:572–80.PubMedCrossRef

20.

Mackenzie I. The clinical presentation of the cerebral angioma: a review of 50 cases. Brain. 1953;76:184–214.PubMedCrossRef

21.

Northfield DWC. Angiomatous malformations of the brain. Guys Hosp Rep. 1940;90:149.

22.

Evans RW. Diagnostic testing for the evaluation of headaches. Neurologic Clin. 1996;14:1–26.CrossRef

23.

Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women. Cerebrovasc Dis. 2004;18:290–5.PubMedCrossRef

24.

Lazar RM, Connaire K, Marshall RS, et al. Developmental deficits in adult patients with arteriovenous malformations. Arch Neurol. 1999;56:103–6.PubMedCrossRef

25.

Hai J, Wan JF, Lin Q, et al. Cognitive dysfunction induced by chronic cerebral hypoperfusion in a rat model associated with arteriovenous malformations. Brain Res. 2009;1301:80–8.PubMedCrossRef

26.

Hai J, Su SH, Lin Q, et al. Cognitive impairment and changes of neuronal plasticity in rats of chronic cerebral hypoperfusion associated with cerebral arteriovenous malformations. Acta Neurologica Belgica. 2010;110:180–5.PubMed

27.

McKissock W, Paterson JH. A clinical survey of intracranial angiomas with special reference to their mode of progression and surgical treatment: a report of 110 cases. Brain. 1956;79:233–66.PubMedCrossRef

28.

McCormick WF, Nofzinger JD. "Cryptic" vascular malformations of the central nervous system. J Neurosurg. 1966;24:865–75.PubMedCrossRef

29.

Guidetti B, Delitala A. Intracranial arteriovenous malformations. Conservative and surgical treatment. J Neurosurg. 1980;53:149–52.PubMedCrossRef

30.

•• Choi JH, Mast H, Sciacca RR, et al. Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke. 2006;37:1243–7. The clinical outcomes are far more mild from bAVMs than from other forms of primary brain hemorrhage.

31.

•• van Beijnum J, Lovelock CE, Cordonnier C, et al. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain. 2009;132:537–43. Population-based study.

32.

• Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65:476–83. Widely-used grading system for predicting outcome from surgery: size, location and 'eloquence' are the major variables.

33.

Du R, Dowd CF, Johnston SC. et al. Interobserver variability in grading of brain arteriovenous malformations using the Spetzler-Martin system. Neurosurgery. 2005;57:668–75; discussion 75.

34.

Ogilvy CS, Stieg PE, Awad I, et al. AHA Scientific Statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council. American Stroke Association. Stroke. 2001;32:1458–71.PubMedCrossRef

35.

• Hartmann A, Mast H, Mohr JP, et al. Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke. 2005;36:2431–5. Outcomes vary by treatment modality.

36.

• Lawton MT, Du R, Tran MN, et al. Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery. 2005;56:485–93; discussion −93. Outcomes worse for those who had not bled.

37.

• Maruyama K, Kawahara N, Shin M, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352:146–53. Those not having bled prior to therapy have more frequent hemorrhage from radiotherapy.

38.

Parkhutik V, Lago A, Tembl JI, et al. Postradiosurgery hemorrhage rates of arteriovenous malformations of the brain: influencing factors and evolution with time. Stroke. 2012;43:1247–52.PubMedCrossRef

39.

•• van Beijnum J, van der Worp HB, Buis DR. et al. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA. 2011;306:2011–9. Major review article justifying a clinical trial.

40.

Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg. 1990;73:387–91.PubMedCrossRef

41.

Mast H, Young WL, Koennecke HC, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350:1065–8.PubMedCrossRef

42.

• Mohr JP, Moskowitz AJ, Parides M. et al. Hull down on the horizon: a Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA) Trial. Stroke. 2012;43:1744–5. Rebuttal to the latest criticisms of the ARUBA trial.

43.

Hernesniemi JA, Dashti R, Juvela S, et al. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63:823–9; discussion 9–31.

44.

Laakso A, Dashti R, Juvela S, et al. Risk of hemorrhage in patients with untreated Spetzler-Martin grade IV and V arteriovenous malformations: a long-term follow-up study in 63 patients. Neurosurgery. 2011;68:372–7; discussion–8.

45.

Berman MF, Hartmann A, Mast H, et al. Determinants of resource utilization in the treatment of brain arteriovenous malformations. AJNR. 1999;20:2004–8.PubMed

46.

Brown Jr RD. Unruptured brain AVMs: to treat or not to treat. Lancet Neurol. 2008;7:195–6.PubMedCrossRef

47.

Kim H, Pourmohamad T, McCulloch CE, et al. Multicenter study of predictors for intracranial haemorrhage risk in the natural history of brain arteriovenous malformations (bAVM). 1st World AVM Congress. Edinburgh; 2012.

48.

•• Stapf C, Mast H, Sciacca RR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66:1350–5. Lowest risk for those with no deep bAVM location or deep venous drainage.

49.

Stapf C, Mohr JP, Choi JH, et al. Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol. 2006;19:63–8.PubMedCrossRef

50.

Stapf C, Mohr JP. Unruptured brain arteriovenous malformations should be treated conservatively: yes. Stroke. 2007;38:3308–9.PubMedCrossRef

51.

Cockroft KM. Unruptured brain arteriovenous malformations should be treated conservatively: no. Stroke. 2007;38:3310–1.PubMedCrossRef

52.

Mohr JP, Moskowitz AJ, Stapf C, et al. The ARUBA trial: current status, future hopes. Stroke. 2010;41:e537–40.PubMedCrossRef

53.

Ross J, Al-Shahi Salman R. Interventions for treating brain arteriovenous malformations in adults. Cochrane Database Syst Rev. 2010:CD003436.

54.

Frenzel T, Lee CZ, Kim H, et al. Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. Cerebrovasc Dis. 2008;25:157–63.PubMedCrossRef

55.

Fiehler J, Stapf C. ARUBA–beating natural history in unruptured brain AVMs by intervention. Neuroradiology. 2008;50:465–7.PubMedCrossRef

56.

Mathiesen T. Arguments against the proposed randomised trial (ARUBA). Neuroradiology. 2008;50:469–71.PubMedCrossRef

57.

Cockroft KM, Jayaraman MV, Amin-Hanjani S, et al. A perfect storm: how a randomized trial of unruptured brain arteriovenous malformations' (ARUBA's) trial design challenges notions of external validity. Stroke. 2012;43:1979–81.PubMedCrossRef

58.

Raymond J, Naggara O, Guilbert F, Altman DG. Assessing prognosis from nonrandomized studies: an example from brain arteriovenous malformations. AJNR. 2011;32:809–12.PubMedCrossRef

59.

Houdart E. The need for new regulations on randomized clinical trials in surgical treatments. Neuroradiology. 2010;52:1061–2.PubMedCrossRef

60.

•• Kim H, McCulloch CE, Johnston SC. et al. Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture. Am J Epidemiol. 2010;171:1317–22. Calculations of risk for hemorrhage based on date of discovery vs, assumption of presence since birth.

61.

Ovalle F, Shay SD, Mericle RA. Delayed intracerebral hemorrhage after uneventful embolization of brain arteriovenous malformations is related to volume of embolic agent administered: multivariate analysis of 13 predictive factors. Neurosurgery. 2012;70:313–20.PubMedCrossRef

62.

Mohr JP, Mast H, Kejda-Scharler J, et al. Proposal for an AVM Registry. 1st World AVM Congress. Edinburgh; 2012.

63.

Lazar RM, Marshall RS, Pile-Spellman J, et al. Anterior translocation of language in patients with left cerebral arteriovenous malformation. Neurology. 1997;49:802–8.PubMedCrossRef

64.

Lepski G, Honegger J, Liebsch M, et al. Safe resection of arteriovenous malformations in eloquent motor areas aided by functional imaging and intraoperative monitoring. Neurosurgery. 2012;70:276–88; discussion 88–9.

65.

Koga T, Maruyama K, Kamada K, et al. Outcomes of diffusion tensor tractography-integrated stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;82:799–802.PubMedCrossRef

66.

Ichikawa T, Suzuki K, Sasaki T, et al. Utility and the limit of motor evoked potential monitoring for preventing complications in surgery for cerebral arteriovenous malformation. Neurosurgery. 2010;67:ons222–8; discussion 8.

67.

Kejda-Scharler J, DeLaPaz R, Mohr JP. Use of MRI, fMRI, and DTI for interventional decision after minimal AVM haemorrhage 1st World AVM Congress. Edinburgh; 2012.

Titel: Diagnosis and Treatment of Arteriovenous Malformations
verfasst von: J. P. Mohr
J. Kejda-Scharler
J. Pile-Spellman
Publikationsdatum: 01.02.2013
Verlag: Current Science Inc.
Erschienen in: Current Neurology and Neuroscience Reports / Ausgabe 2/2013
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-012-0324-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

Drug Abuse and Stroke

Biomarkers and Predictors of Restorative Therapy Effects After Stroke

Aspirin and Clopidogrel for Prevention of Ischemic Stroke

Endovascular Treatment of Ruptured Intracranial Aneurysms